Global Injectable Drug Delivery Devices market cagr 10.0%

Injectable Drug Delivery Devices Market

Injectable Drug Delivery Devices Market Scope: Industry Analysis, Market Size, Growth, Trends Till

Request Sample Report

Injectable Drug Delivery Devices Market Size and Growth

The global Injectable Drug Delivery Devices market is projected to reach a value of $XX billion by 2025, growing at a CAGR of XX% during the forecast period. Key factors driving market growth include increasing prevalence of chronic diseases and demand for targeted drug delivery systems. Various advancements in technology are also contributing to market expansion.

Request Sample Report

Companies Covered

(Covid 19 Impact Covered)

◍ Dickinson and Company

◍ Baxter International

◍ Schott

◍ Eli Lilly

◍ Pfizer

◍ Gerresheimer

◍ Terumo

◍ Antares Pharma

◍ Novo Nordik

◍ Sanofi

◍ Unilife

◍ Zogenix

◍ Hospira

◍ Presage Bioscience

◍ MicroCHIPS

◍ Pearl Therapeutics

◍ Genentech

◍ Bend Research

The competitive landscape of the Injectable Drug Delivery Devices Market includes companies such as BD, Baxter International, Schott, Eli Lilly, Pfizer, Gerresheimer, Terumo, Antares Pharma, Novo Nordisk, Sanofi, Unilife, Zogenix, Hospira, Presage Bioscience, MicroCHIPS, Pearl Therapeutics, Genentech, and Bend Research. These companies develop and manufacture devices such as prefilled syringes, auto-injectors, and needle-free injectors, which are essential for administering medications effectively. The use of these devices helps to enhance patient compliance, convenience, and safety in drug delivery, thereby contributing to the growth of the market.

- BD: $17.12 billion (FY 2020)

- Baxter International: $11.58 billion (FY 2020)

- Eli Lilly: $24.54 billion (FY 2020)

- Pfizer: $41.91 billion (FY 2020)

Request Sample Report

Market Segmentation

By Application

Immune Disorder

Cancer

Diabetes

Others

Request Sample Report

By Product

Devices

Formulation

Market Growth

Request Sample Report

$ X Billion USD